FATE THERAPEUTICS INC
Develops iPSC-derived cellular immunotherapies for cancer and autoimmune disorders.
FATE | US
Overview
Corporate Details
- ISIN(s):
- US31189P1021
- LEI:
- Country:
- United States of America
- Address:
- 12278 SCRIPPS SUMMIT DRIVE, 92131 SAN DIEGO
- Website:
- https://fatetherapeutics.com/
- Sector:
- Manufacturing
Description
Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and autoimmune disorders. The company utilizes its proprietary induced pluripotent stem cell (iPSC) product platform to create master iPSC lines for the mass production of universal, off-the-shelf cell products. These multiplexed-engineered cell candidates are designed with novel synthetic controls to deliver multiple therapeutic mechanisms. This approach aims to overcome key limitations inherent to other cell therapies, with the goal of making treatments more effective, routine, and accessible for patients with life-threatening diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all FATE THERAPEUTICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FATE THERAPEUTICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FATE THERAPEUTICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
